A
12.03
0.04 (0.33%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Drug Manufacturers - General (US) | 混合的 | 看涨 |
| Drug Manufacturers - General (全球的) | 混合的 | 看涨 | |
| 股票 | Amarin Corporation plc | 混合的 | 混合的 |
AIStockmoo 评分
-0.7
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | 3.0 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | -2.5 |
| 相对估值 | NA |
| 财务健康 | NA |
| AI Insight | NA |
| 平均 | -0.67 |
|
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States. |
|
| 部门 | Healthcare |
| 行业 | Drug Manufacturers - General |
| 内部持股比例 | 1.88% |
| 机构持股比例 | 17.94% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Waterfront Wealth Inc. | 30 Jun 2026 | 213,949 |
| Lcm Capital Management Inc | 30 Jun 2026 | 51,362 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合